E Fund Management’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-24,853
| Closed | -$25.4K | – | 424 |
|
|
2024
Q4 | $25.4K | Buy |
+24,853
| New | +$25.4K | ﹤0.01% | 393 |
|
|
2023
Q2 | – | Sell |
-35,003
| Closed | -$62K | – | 334 |
|
|
2023
Q1 | $62K | Sell |
35,003
-2,004
| -5% | -$3.55K | ﹤0.01% | 330 |
|
|
2022
Q4 | $116K | Buy |
37,007
+9,284
| +33% | +$29.1K | 0.01% | 324 |
|
|
2022
Q3 | $136K | Sell |
27,723
-3,869
| -12% | -$19K | 0.01% | 321 |
|
|
2022
Q2 | $131K | Buy |
31,592
+8,491
| +37% | +$35.2K | 0.01% | 315 |
|
|
2022
Q1 | $134K | Buy |
23,101
+11,383
| +97% | +$66K | ﹤0.01% | 311 |
|
|
2021
Q4 | $88K | Buy |
11,718
+672
| +6% | +$5.05K | ﹤0.01% | 291 |
|
|
2021
Q3 | $100K | Buy |
+11,046
| New | +$100K | ﹤0.01% | 259 |
|
|
2021
Q1 | $151K | Buy |
+12,015
| New | +$151K | 0.01% | 222 |
|